Asset Purchase Agreement by and between Orgenesis Inc. and Tamir Biotechnology, Inc. April 12, 2020Asset Purchase Agreement • April 13th, 2020 • Orgenesis Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 13th, 2020 Company Industry JurisdictionThis Asset Purchase Agreement (this "Agreement") is made and entered into as of April 12, 2020 (the "Agreement Date"), by and between ORGENESIS INC., a Nevada corporation ("Purchaser"), and TAMIR BIOTECHNOLOGY, INC., a Delaware corporation ("Seller").